Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease

Objective Tissue transglutaminase is the autoantigen recognized by the sera of celiac patients. An enzyme-linked immunosorbent assay (ELISA) based on guinea-pig tissue transglutaminase was recently used to measure serum tissue transglutaminase antibodies for the diagnosis of celiac disease. We determine the sensitivity and specificity of an ELISA test based on the use of human recombinant transglutaminase, compared with the guinea pig transglutaminase ELISA and IgA antiendomysium antibodies. Methods Serum samples were tested from 65 patients with intestinal biopsy proven celiac disease, from 10 patients with Crohn's disease, and from 150 healthy blood donors. Results Human transglutaminase ELISA identified 64 of 65 celiac patients, whereas the guinea pig transglutaminase ELISA and IgA antiendomysium antibodies identified 58 of 65 and 60 of 65 subjects, respectively. The three tests showed comparable specificity. Conclusions These results proved that the human tissue transglutaminase-based ELISA represents a cost-effective strategy for identifying both symptomatic and atypical forms of celiac disease and could mean that intestinal biopsy need no longer be the gold standard for diagnosing this clinical condition. Furthermore, early identification and treatment of patients with celiac disease in an outpatient setting could have significant implications for reducing long-term morbidity and can produce major savings in future health care costs.

[1]  E. Savilahti,et al.  IgA endomysium antibodies on human umbilical cord: an excellent diagnostic tool for celiac disease in childhood. , 1997, Journal of pediatric gastroenterology and nutrition.

[2]  Sblattero Daniele,et al.  PHAGE ANTIBODY LIBRARY FROM CELIAC DISEASE PATIENT , 1999 .

[3]  G. Corazza,et al.  Tissue transglutaminase antibodies in celiac disease , 1999, American Journal of Gastroenterology.

[4]  R. Marzari,et al.  HUMAN TISSUE TRANSGLUTAMINASE ELISA: A POWERFUL MASS SCREENING DIAGNOSTIC ASSAY FOR COELIAC DISEASE , 1999, Journal of Pediatric Gastroenterology and Nutrition.

[5]  L. Greco,et al.  IgA antibodies to tissue transglutaminase: An effective diagnostic test for celiac disease. , 1999, The Journal of pediatrics.

[6]  K. Pittschieler,et al.  Endomysium antibodies in coeliac disease: an improved method. , 1994, Gut.

[7]  K. Rostami.  Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. , 1999 .

[8]  J. Partanen,et al.  Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. , 1998, Scandinavian journal of gastroenterology.

[9]  T. Not,et al.  Anti-endomysium antibody on human umbilical cord vein tissue: an inexpensive and sensitive diagnostic tool for the screening of coeliac disease , 1997, European Journal of Pediatrics.

[10]  D. Schuppan,et al.  Autoantibodies to tissue transglutaminase as predictors of celiac disease. , 1998, Gastroenterology.

[11]  E. Chiocca,et al.  Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. , 1991, The Journal of biological chemistry.

[12]  E. Bonifacio,et al.  Tissue transglutaminase and combined screening for coeliac disease and type 1 diabetesassociated autoantibodies , 1998, The Lancet.

[13]  I. Korponay-Szabó,et al.  Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. , 1998, Gastroenterology.

[14]  J. Walker-Smith.  Management of infantile gastroenteritis. , 1990, Archives of disease in childhood.

[15]  C. Catassi,et al.  High prevalence of undiagnosed coeliae disease in 5280 Italian students screened by antigliadin antibodies , 1995, Acta paediatrica.

[16]  G. Corazza,et al.  Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: an Italian multicentre study , 1998, Gut.

[17]  A. Ferguson,et al.  Similarities in intestinal humoral immunity in dermatitis herpetiformis without enteropathy and in coeliac disease , 1990, The Lancet.

[18]  James M. Holmes,et al.  ‘Optimal’ model selection when the true relationship is weak and occurs with a delay , 1989 .

[19]  L. Sollid,et al.  New tool to predict celiac disease on its way to the clinics. , 1998, Gastroenterology.

[20]  D. Jewell,et al.  Coeliac disease in primary care: case finding study , 1999, BMJ.

[21]  D. Schuppan,et al.  Identification of tissue transglutaminase as the autoantigen of celiac disease , 1997, Nature Medicine.

[22]  E. Thorsby,et al.  HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. , 1993, Gastroenterology.

[23]  L. Greco,et al.  Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. , 1999, Gastroenterology.

[24]  G. Holmes,et al.  Malignancy in coeliac disease--effect of a gluten free diet. , 1989, Gut.